Best Life Sciences Companies in Nazareth, Israel
The 31 best Life Sciences companies in Nazareth, Israel in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Paragate Medical.
Our analysis of 50 Life Sciences companies
$2.2b in tracked funding; 75% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2024.
Ranked: Best Life Sciences companies in Nazareth
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Paragate Medical Implantable device for congestive heart failure patients | $13M | 46 mo ago | Seed | Yair Feld Co-Founder & Medical Director | 2016 | — | — | — |
| 2 | Nurami Medical Developer of nanofiber and sealant technology for the soft tissue repair 40Moat top 25%Growth top 35%Product top 35%Patents top 37% All 9 signals ▾Moattop 25% Growthtop 35% Producttop 35% Patentstop 37% Fundingtop 41% Innovationtop 42% Globalbottom 40% Techbottom 38% Marketbottom 28% Moat: Editorial + unicorn rating 7/10 · IP moat: 37 patents Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 40/100 | $12M | 20 mo ago | Series C | — | 2014 | WordPressMySQLPHP+15 | 37 patents Biocompatible adhesive and multilayer tissue matrices for wound repair and regenerative medicine | — |
| 3 | Virility Medical Provider of a skin patch for the treatment of premature ejaculation | $10M | 51 mo ago | Series A | — | 2016 | WixSentryZendesk+19 | 46 patents Electrical stimulation devices for male sexual function, ejaculation control, and orgasm enhancement | — |
| 4 | Ark Surgical Manufacturer of organ retrieval devices in laparoscopic surgery | $3M | 31 mo ago | Seed | Abraham Yaari Co-Founder | 2017 | WordPressMySQLPHP+16 | 24 patents Minimally invasive surgery: laparoscopic tissue containment and workspace devices for organ access | — |
| 5 | Aqueduct Medical Developing cervical dilator device for intrauterine procedures | $1M | — | Seed | Omer Harpaz Founder | 2013 | — | — | — |
| 6 | Guide in Medical Developing guided intubation systems for trachea visualization | $1M | 117 mo ago | Seed | Itai Hayut Co-Founder | 2015 | — | — | — |
| 7 | IDD Therapeutics Developing small molecule drugs for cancer | $1M | — | Deadpooled | Anwar RAYAN Co-Founder | 2010 | — | — | — |
| 8 | Implant-B Multi-piece dental implant for the treatment of peri-implantitis | $795K | 122 mo ago | Deadpooled | Tsachi Doner CEO | 2014 | — | 14 patents Renewable dental implants and one-time abutment/removable sleeve systems for dentistry | — |
| 9 | CartiCure Early stage MedTech company focusing on cartilage repair products | $600K | — | Deadpooled | Gila maor Founder & CTO | 2005 | — | 5 patents Regenerative cartilage therapies using engineered chondrocyte films | — |
| 10 | EndoGI Developer of a stent delivery system | $112K | 82 mo ago | Funding Raised | Ronny Barak Co-Founder | 2017 | — | — | — |
Top 12 Life Sciences companies in Nazareth
#1
Series C · Nazareth, Northern District · founded 2014 · 16 employees$12.4Mraised▾
Nurami Medical is a developer of nanofiber and sealant technology for soft tissue repair. It has developed its first product which is a dural substitute patch for neurosurgeries to prevent cerebrospinal fluid leakage and regenerate the damaged dura protecting the brain. The product is in preclinical trials. It is also working on the next-generation of ArtiFascia that will be able to adhere to tissues without the need for sutures.
- Mar 2025Series C$30M
- Nov 2020Series B$6M
- Dec 2016Seed$645.8K
- 2014Seed$800K
#2
Seed · Nazareth, Northern District · founded 2016 · 10 employees$13.4Mraised▾
Paragate Medical is developing an implantable device for the heart failure patients. Based on the specific anatomical membrane’s properties and through a patented absorption element, it is developing its flagship product which is a minimally invasive device that is capable of removing the excess extracellular fluid from the body & offers a therapeutic benefit by reducing blood volume & pressure overload. As of November 2016, the company is operating within NGT3 incubator & has finished preclinical feasibility testing.
- Jan 2023Grant (prize money)$11M
- Jul 2021Grant (prize money)$59.4K
- Aug 2019Grant (prize money)$2.3M
- Nov 2018Grant (prize money)$56.9K
#3
Seed · Nazareth, Northern District · founded 2017 · 10 employees$3.2Mraised▾
Manufacturer of organ retrieval devices in laparoscopic surgery. The company offers LapBox, is a groundbreaking tissue containment system that reduce the risk of cancerous tissue dispersion during laparoscopic surgery and enable contained minimally invasive procedures instead of high-risk open surgery.
- Mar 2024Seed$1.1M
- Jun 2021Seed$2.1M
#4
Series A · Nazareth, Northern District · founded 2016 · 9 employees$10Mraised▾
Provider of a skin patch for the treatment of premature ejaculation. Its flagship product is a disposable patch that carries an electronic module that generates neuromuscular electrical stimulation and delivers it transcutaneously to the adjacent musculature, thus delaying the onset of the premature phase of ejaculation.
#5
Seed · Nazareth, Northern District · founded 2015 · 2 employees$1.2Mraised▾
Guide in Medical is a medical device company focused on developing a guided intubation system for the identification and visualization of the trachea. Its product is an already existing guiding element device with an external disposable signal source that enables it to distinguish the trachea from the esophagus and leads the caregiver to the correct position of the trachea. It also developed a special tracking software that is capable of detecting the signal, analyzing and magnifying it. It is planning for the complete product development by Q3-2016 and is looking for CE market approval in Q4-2016 and for FDA market approval in Q1-2017.
- Jan 2017Seed$500K
- 2015Seed$750K
#6
Seed · Nazareth, Northern District · founded 2013 · 4 employees$1.3Mraised▾
Developer of medical device designed to alleviate the complications of cervical dilation prior to intrauterine procedures. The company's products are designed to alleviate the discomfort and potential complications that women risk when undergoing cervical dilation prior to intrauterine procedures, enabling healthcare providers to operate and provide an effective dilation procedure.
#7
Deadpooled · Nazareth, Northern District · founded 2010$1Mraised▾
IDD Therapeutics is focussed on developing drugs for cancer. Using its proprietary Intelligent Learning Engine platform, it is screening databases of chemicals targeted towards specific biological targets and indications. Its lead candidate IDD-1040, is a prodrug of Paclitaxel consisting of a neuroprotective antioxidant moiety which claims to exhibit higher efficacy than paclitaxel. The company is planning to finalize the preclinical and phase 1/2 studies by the end of 2016 for the treatment of solid tumors and metastasis.
- Seed$1M
#8
Deadpooled · Nazareth, Northern District · founded 2014 · 2 employees$794.7Kraised▾
Implant-B is engaged in the field of dental implantology & is developing a multi-piece dental implant for the definitive treatment of peri-implantitis (PI) while preserving the original implant spatial position and dental restoration. As of November 2016, the company operates within the framework of NGT3 technology incubator & has its flagship product in the development stages.
- Aug 2016Seed$794.7K
#9
Deadpooled · Nazareth, Northern District · founded 2005$600Kraised▾
CartiCure is an early stage MedTech company focusing on cartilage repair products. The company's technological platform generates hyaline cartilage-producing cells for transplantation into damaged joints. Its first product, Cartimove is for the treatment of knee cartilage damage resulting from trauma injuries and its future products are targeted at the Osteoarthritis market.
#10
Funding Raised · Nazareth, Northern District · founded 2017 · 5 employees$112.4Kraised▾
EndoGI Medical has developed a stent delivery system. The company has developed the stent delivering system for the treatment of obstructed urinary, biliary or pancreatic leaks or fluid drainage. The features of the system are larger stent diameter, maintained guide wire location and covered SEMS.
- Dec 2019Grant (prize money)$56K
- Jul 2019Grant (prize money)$56.4K
#11
Funding Raised · Nazareth, Northern District · founded 2017 · 9 employees—raised▾
Developer of a medical device designed to modify human plasma to improve treatment for massive bleeding. The company's device effectively removes pepsinogen, a specific protein related to the fibrinolytic system, from blood plasma to prevent massive bleeding as well as contains a module unit that can be incorporated in conventional apheresis systems, craeted to remove key factors of the fibrinolytic system, enabling healthcare professionals to receive blood and plasma products with enhanced coagulation properties for improved treatment of excessive bleeding.
#12
Funding Raised · Nazareth, Northern District · founded 2017—raised▾
Developer of gene-targeted therapies for infectious diseases. The company is developing RNA-based COVID 19 vaccines that rely on novel nanoparticle vehicles which can safely and effectively deliver them to target cells and organs.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Israel
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 267 Israel-affiliated papers.
- Ministry of Agriculture118
- Hebrew University of Jerusalem29
- Agricultural Research Organization25
- Tel Aviv University21
- Ben-Gurion University of the Negev19
- Mitochondrion1→5
- Gene1→18
- Plant disease resistance1→7
- Resistance (ecology)2→6
- Agriculture3→6
Where biotechnology is researched across Israel
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.